New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
about
Peptide-based probes for targeted molecular imaging.Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analogNovel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers.[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical studyAffibody-mediated PET imaging of HER3 expression in malignant tumours.Copper-64 Radiopharmaceuticals for Oncologic ImagingIlluminating somatostatin analog action at neuroendocrine tumor receptorsPreparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors.Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy.Radiopharmaceutical development of radiolabelled peptides.Management of the hormonal syndrome of neuroendocrine tumors.Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.Safety and accuracy of 68Ga-DOTATOC PET/CT in children and young adults with solid tumors.Reassessment of sst3 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-5.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Q33526620-1FD3747F-B2BB-4C75-B6E3-4DE92EDD6E9FQ34514544-733650AA-20AB-4BA1-B92A-69C0C6237AA2Q35650466-200A626E-77D9-4906-85DE-6B0CC7DDB50DQ36125639-030497D7-08EA-4928-95DC-12409F7D3FAAQ36174716-673CFC67-519B-4F89-9C2C-0DC6742675A6Q37126530-51578DDD-24E3-49D1-962C-64DDBCE88E1EQ37443562-8F1D7330-CF2A-492A-9350-5F71A295A584Q37479595-016C3ABD-7510-4994-A383-7C7F8C39BAF2Q37975101-B0DE850B-EA1B-45CD-9427-7E082E4FC80FQ37990399-96A87841-EDEF-46FD-B7F3-B40399876D1AQ41832570-9F8D4A1F-EEFF-44A7-BB03-809D62807365Q45996806-E02262BB-1CBC-460E-BCFE-2A7AA8E3A70BQ47155891-5796B411-0DCE-40C0-94E6-40222A486112Q48616839-019B834C-F4E4-4444-88AE-6E5D6C202B59Q57144951-74154DE1-7CA0-4821-B19A-754BCA238ABF
P2860
New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
New pansomatostatin ligands an ...... lization, and tumor targeting.
@en
New pansomatostatin ligands an ...... lization, and tumor targeting.
@nl
type
label
New pansomatostatin ligands an ...... lization, and tumor targeting.
@en
New pansomatostatin ligands an ...... lization, and tumor targeting.
@nl
prefLabel
New pansomatostatin ligands an ...... lization, and tumor targeting.
@en
New pansomatostatin ligands an ...... lization, and tumor targeting.
@nl
P2093
P1476
New pansomatostatin ligands an ...... lization, and tumor targeting.
@en
P2093
Damian Wild
Hanwen Zhang
Helmut R Maecke
Klaus-Peter Eisenwiener
Mihaela Ginj
Renzo Cescato
Stefan Schulz
P304
P356
10.1158/1078-0432.CCR-07-1687
P407
P577
2008-04-01T00:00:00Z